Literature DB >> 23305890

Baroreflex and chemoreflex controls of sympathetic activity following intermittent hypoxia.

Christopher S Freet1, James F Stoner, Xiaorui Tang.   

Abstract

There is a large amount of evidence linking obstructive sleep apnea (OSA), and the associated intermittent hypoxia that accompanies it, with the development of hypertension. For example, cross-sectional studies demonstrate that the prevalence of hypertension increases with the severity of OSA (Bixler et al., 2000; Grote et al., 2001) and an initial determination of OSA is associated with a three-fold increase for future hypertension (Peppard et al., 2000). Interestingly, bouts of intermittent hypoxia have also been shown to affect sympathetic output associated with the baroreflex and chemoreflex, important mechanisms in the regulation of arterial blood pressure. As such, the possibility exists that changes in the baroreflex and chemoreflex may contribute to the development of chronic hypertension observed in OSA patients. The aim of the current article is to briefly review the response of the baroreflex and chemoreflex to intermittent hypoxic exposure and to evaluate evidence for the hypothesis that modification of these autonomic reflexes may, at least in part, support the comorbidity observed between chronic hypertension and OSA.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23305890     DOI: 10.1016/j.autneu.2012.12.005

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  17 in total

1.  Prenatal hypoxia in rats increased blood pressure and sympathetic drive of the adult offspring.

Authors:  Pavel Svitok; Lubos Molcan; Katarina Stebelova; Anna Vesela; Natalia Sedlackova; Eduard Ujhazy; Mojmir Mach; Michal Zeman
Journal:  Hypertens Res       Date:  2016-02-25       Impact factor: 3.872

Review 2.  Apneic Sleep, Insufficient Sleep, and Hypertension.

Authors:  Meghna P Mansukhani; Naima Covassin; Virend K Somers
Journal:  Hypertension       Date:  2019-04       Impact factor: 10.190

3.  Diet and exercise in obstructive sleep apnea patients with obesity: I'll breathe to that!

Authors:  David Gozal
Journal:  Obesity (Silver Spring)       Date:  2015-07-14       Impact factor: 5.002

Review 4.  Sleep, death, and the heart.

Authors:  Meghna P Mansukhani; Shihan Wang; Virend K Somers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-17       Impact factor: 4.733

5.  Chronic intermittent hypoxia and hypercapnia inhibit the hypothalamic paraventricular nucleus neurotransmission to parasympathetic cardiac neurons in the brain stem.

Authors:  Olga Dergacheva; Jhansi Dyavanapalli; Ramón A Piñol; David Mendelowitz
Journal:  Hypertension       Date:  2014-06-23       Impact factor: 10.190

6.  Ambulatory Blood Pressure Monitoring in Chinese Patients with Obstructive Sleep Apnea.

Authors:  Yan Ma; Shuchen Sun; Chung-Kang Peng; Yeming Fang; Robert J Thomas
Journal:  J Clin Sleep Med       Date:  2017-03-15       Impact factor: 4.062

7.  White matter alteration and autonomic impairment in obstructive sleep apnea.

Authors:  Hsiu-Ling Chen; Chih-Cheng Huang; Hsin-Ching Lin; Cheng-Hsien Lu; Pei-Chin Chen; Kun-Hsien Chou; Mao-Chang Su; Michael Friedman; Ching-Po Lin; Wei-Che Lin
Journal:  J Clin Sleep Med       Date:  2020-01-13       Impact factor: 4.062

Review 8.  Integrated Cardio-Respiratory Control: Insight in Diabetes.

Authors:  Luciano Bernardi; Lucio Bianchi
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 9.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

10.  High-fat diet increases respiratory frequency and abdominal expiratory motor activity during hypercapnia.

Authors:  Guilherme F Speretta; Eduardo Vieira Lemes; Regina C Vendramini; José V Menani; Daniel B Zoccal; Eduardo Colombari; Débora S A Colombari; Mirian Bassi
Journal:  Respir Physiol Neurobiol       Date:  2018-10-09       Impact factor: 1.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.